您的当前位置:首页 > 行业数据 > 呋喹替尼在研管线进展(截至2024年7月)
图片属性
图片格式:PNG 图片大小:531KB 图片尺寸:2302*697
同报告图片
 / 4
呋喹替尼在研管线进展(截至2024年7月)_第1页
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
呋喹替尼在研管线进展(截至2024年7月)_第2页
fCDlubTku70gfCDluILlnLrplIDllK7pop3vvIjnmb7kuIfnvo7lhYPvvIkgfCDlop7plb/njocgfCBDRVLlop7plb/njocgfAp8LS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS18LS0tLS0tLS0tLS0tfAp8IDIwMjIgfCA5My41ICAgICAgICAgICAgICAgICB8ICAgICAgICB8ICAgICAgICAgICAgfAp8IDIwMjMgfCAxMDcuNSAgICAgICAgICAgICAgICB8ICsxNSUgICB8ICsyMiUgICAgICAgfAp8IDIwMjQgfCAxMTUuMCAgICAgICAgICAgICAgICB8ICs3JSAgICB8ICs5JSAgICAgICAgfAoK6LWE5paZ5p2l5rqQ77ya5YWs5Y+45ryU56S65p2Q5paZ77yM5Lit5rOw6K+B5Yi456CU56m25omA
呋喹替尼在研管线进展(截至2024年7月)_第3页
呋喹替尼在研管线进展(截至2024年7月)_第4页
呋喹替尼在研管线进展(截至2024年7月)_第5页
所属报告: 和黄医药-港股公司深度报告:小分子药物研发领军者创新驱动全球化-250401(25页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠